Premium Only Content
Dr. Nina Siragusa - Merck KGaA Darmstadt, Germany - Bridging Science And Nature To Shape Tomorrow
Dr. Nina Siragusa, Ph.D., MBA, is the Strategy, Business, and Data & Digital Lead within the global R&D organization of Merck Healthcare KGaA, Darmstadt, Germany. In this role, she leads strategic projects, manages business operations, and drives digital transformation.
Previously, she served as Chief of Staff to Dr. Laura Matz, Chief Science and Technology Officer at Merck KGaA, Darmstadt, Germany. As part of the Science and Technology Office Leadership Team, she was responsible for fostering cross-sectoral collaboration, innovation, and digitalization across Merck’s three business sectors. She also spearheaded the company’s efforts in Bioconvergence, a multidisciplinary approach that synergizes biology, engineering, data, and digitalization. This initiative promises groundbreaking advancements in healthcare and the life sciences, heralding a new era of scientific collaboration for a healthier, more sustainable future.
Prior to that, Dr. Siragusa contributed to corporate innovation in several leadership roles:
• As Biotechnology Lead of a synthetic biology innovation project,
• As Senior Manager, responsible for creating strategic alignment and building high-performing teams, and
• As Associate Director, focusing on sourcing innovative ideas to generate new business opportunities.
Dr. Siragusa earned her Ph.D. in Biology from the University of Tuebingen, Germany, and conducted research in Europe and the USA, including at Yale University, before joining Merck KGaA, Darmstadt, Germany in 2016.
In 2024, she completed an MBA in Digital Transformation Management with a focus on Digital Leadership at Goethe Business School, Frankfurt, Germany.
Dr. Siragusa is also the lead author of the recently published book, Bioconvergence Revolution: Challenges and Opportunities in Research Productivity. You can find it here:
https://link.springer.com/book/10.1007/978-3-031-61593-1
Home Page Merck KGaA Darmstadt, Germany - https://www.emdgroup.com/en
#NinaSiragusa #MerckGroup #Bioconvergence #Ethics #Collaboration #Fungi #NaturalProducts #Biomimicry #AI #DrugDiscovery #Bioremediation #TranslationalMedicine #SmartManufacturing #DigitalTwins #Supermind #MIT #ResearchFunding #Israel #STEM #Innovation #Science #Technology #Research #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #Podcasting #ViralPodcast
-
1:14:05
Tucker Carlson
20 hours ago“I’ll Win With or Without You,” Teamsters Union President Reveals Kamala Harris’s Famous Last Words
244K387 -
1:58:31
The Dilley Show
20 hours ago $37.78 earnedTrump Conquering Western Hemisphere? w/Author Brenden Dilley 12/23/2024
176K50 -
1:09:59
Geeks + Gamers
21 hours agoSonic 3 DESTROYS Mufasa And Disney, Naughty Dog Actress SLAMS Gamers Over Intergalactic
120K21 -
51:59
The Dan Bongino Show
22 hours agoDemocrat Donor Admits The Scary Truth (Ep. 2393) - 12/23/2024
961K3.2K -
2:32:15
Matt Kohrs
1 day agoRumble CEO Chris Pavlovski Talks $775M Tether Partnership || The MK Show
147K36 -
28:23
Dave Portnoy
1 day agoDavey Day Trader Presented by Kraken - December 23, 2024
177K47 -
59:29
BonginoReport
23 hours agoTrump, Murder Plots, and the Christmas Miracle: Evita + Jack Posobiec (Ep.110) - 12/23/2024
178K174 -
2:59:14
Wendy Bell Radio
1 day agoNothing To See Here
140K81 -
2:12:18
TheDozenPodcast
1 day agoIslam vs Christianity: Bob of Speakers' Corner
120K37 -
14:36
The StoneZONE with Roger Stone
2 days agoRoger Stone Delivers Riveting Speech at Turning Point’s AMFEST 2024 | FULL SPEECH
139K36